PriceTargets.com logo

Waldencast - WALD Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $14.25
  • Forecasted Upside: 74.21%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$8.18 As of 09/28/2023 01:09 PM ET
▼ -0.19 (-2.27%)

This chart shows the closing price for WALD by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Waldencast Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for WALD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for WALD

Analyst Price Target is $14.25
▲ +74.21% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Waldencast in the last 3 months. The average price target is $14.25, with a high forecast of $15.50 and a low forecast of $13.00. The average price target represents a 74.21% upside from the last price of $8.18.

This chart shows the closing price for WALD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Moderate Buy

The current consensus among 3 investment analysts is to moderate buy stock in Waldencast. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
4/5/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
7/4/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/2/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/31/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/31/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/29/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
8/28/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/27/2023

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/24/2023Raymond JamesDowngradeOutperform ➝ Market PerformLow
3/9/2023Telsey Advisory GroupReiterated RatingOutperform$13.00Low
11/17/2022DA DavidsonBoost TargetBuy$12.00 ➝ $15.50Low
9/8/2022DA DavidsonInitiated CoverageBuy$12.00Low
8/22/2022Raymond JamesInitiated CoverageOutperform$11.00Low
8/17/2022Jefferies Financial GroupInitiated CoverageBuy$11.00Low
7/19/2022Telsey Advisory GroupInitiated CoverageOutperform$13.00Low
(Data available from 9/28/2018 forward)

News Sentiment Rating

0.83 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
3/2/2023
  • 4 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/1/2023
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/1/2023
  • 1 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/31/2023
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/30/2023
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/30/2023
  • 1 very positive mentions
  • 1 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
8/29/2023
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/28/2023

Current Sentiment

  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Waldencast logo
Waldencast plc, a skincare company, develops, markets, and sells skin health products worldwide. The company offers approximately 200 cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. It sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force; and through distribution partners. The company was founded in 1988 and is based in White Plains, New York.
Read More

Today's Range

Now: $8.18
Low: $7.93
High: $8.30

50 Day Range

MA: $7.11
Low: $5.45
High: $10.58

52 Week Range

Now: $8.18
Low: $5.00
High: $12.10

Volume

1,317 shs

Average Volume

63,339 shs

Market Capitalization

$879.92 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Waldencast?

The following Wall Street research analysts have issued research reports on Waldencast in the last year: DA Davidson, Raymond James, and Telsey Advisory Group.
View the latest analyst ratings for WALD.

What is the current price target for Waldencast?

2 Wall Street analysts have set twelve-month price targets for Waldencast in the last year. Their average twelve-month price target is $14.25, suggesting a possible upside of 74.2%. DA Davidson has the highest price target set, predicting WALD will reach $15.50 in the next twelve months. Telsey Advisory Group has the lowest price target set, forecasting a price of $13.00 for Waldencast in the next year.
View the latest price targets for WALD.

What is the current consensus analyst rating for Waldencast?

Waldencast currently has 1 hold rating and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for WALD.

What other companies compete with Waldencast?

Other companies that are similar to Waldencast include Olaplex, Yatsen, Edgewell Personal Care, The Hain Celestial Group and Leslie's. Learn More about companies similar to Waldencast.

How do I contact Waldencast's investor relations team?

The company's listed phone number is 917-546-6828 and its investor relations email address is i[email protected]. The official website for Waldencast is www.waldencast.com. Learn More about contacing Waldencast investor relations.